Most cited recent articles in

Transplant International

1.            Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation
Oberbauer, R; Segoloni, G; Campistol, JM; Kreis, H; Mota, A; Lawen, J; Russ, G; Grinyo, JM; Stallone, G; Hartmann, A; Pinto, JR; Chapman, J; Burke, JT; Brault, Y; Neylan, JF (vol. 18, issue 1)
Click here to view article: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1432-2277.2004.00052.x

2.            Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy
Dittrich, E; Schmaldienst, S; Soleiman, A; Horl, WH; Pohanka, E (vol. 17, issue 4)
Click here to view article: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1432-2277.2004.tb00431.x

3.            Clinical application of sirolimus in renal transplantation: an update
Chueh, SCJ; Kahan, BD (vol. 18, issue 3)
Click here to view article: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1432-2277.2004.00039.x

4.            Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors
Nashan, B (vol. 17, issue 6)
Click here to view article: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1432-2277.2004.tb00444.x

5.            Abbreviated mycophenolic acid AUC from C0, C1, C2, and C4 is preferable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy
Filler, G (vol. 17, issue 3)
Click here to view article: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1432-2277.2004.tb00415.x

6.            Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil
Hardinger, KL; Brennan, DC; Lowell, J; Schnitzler, MA (vol. 17, issue 10)
Click here to view article: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1432-2277.2004.tb00394.x

7.            Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation
Giostra, E; Kullak-Ublick, GA; Keller, W; Fried, R; Vanlemmens, C; Kraehenbuhl, S; Locher, S; Egger, HP; Clavien, PA; Hadengue, A; Mentha, G; Morel, P; Negro, F (vol. 17, issue 4)
Click here to view article: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1432-2277.2004.tb00424.x

8.            Clearance of C4d deposition after successful treatment of acute humoral rejection in follow-up biopsies: a report of three cases
Koller, H; Steurer, W; Mark, W; Margreiter, R; Lhotta, K; Mayer, G; Rosenkranz, AR (vol. 17, issue 4)
Click here to view article: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1432-2277.2004.tb00425.x

9.            Current practices of donor pancreas allocation in the UK: future implications for pancreas and islet transplantation
Ridgway, DM; White, SA; Kimber, RM; Nicholson, ML (vol. 18, issue 7)
Click here to view article: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1432-2277.2005.00144.x

10.        Bile duct complications after liver transplantation
Pascher, A; Neuhaus, P (vol. 18, issue 6)
Click here to view article: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1432-2277.2005.00123.x

11.        In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose
Rydberg, L; Bengtsson, A; Samuelsson, O; Nilsson, K; Breimer, ME (vol. 17, issue 11)
Click here to view article: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1432-2277.2004.tb00492.x

12.        Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens
Wlodarczyk, Z; Walaszewski, J; Perner, F; Vitko, S; Ostrowski, M; Bachleda, P; Kokot, F; Klinger, M; Szenohradszky, P; Studenik, P; Navratil, P; Asztalos, L; Rutkowski, B; Kalmar, KN; Hickey, D (vol. 18, issue 2)
Click here to view article: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1432-2277.2004.00011.x

13.        Long-term efficacy and safety of mycophenolate mofetil in liver transplant recipients with calcineurin inhibitor-induced renal dysfunction
Koch, RO; Graziadei, IW; Schulz, F; Nachbaur, K; Konigsrainer, A; Margreiter, R; Vogel, W (vol. 17, issue 9)
Click here to view article: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1432-2277.2004.tb00481.x

14.        Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival
Cho, HR; Kwon, B; Yagita, H; La, S; Lee, EA; Kim, JE; Akiba, H; Kim, J; Suh, JH; Vinay, DS; Ju, SA; Kim, BS; Mittler, RS; Okumura, K; Kwon, BS (vol. 17, issue 7)
Click here to view article: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1432-2277.2004.tb00454.x

15.        Effect of University of Wisconsin organ-preservation solution on haemorheology
van der Plaats, A; 't Hart, NA; Morariu, AM; Verkerke, GJ; Leuvenink, HGD; Ploeg, RJ; Rakhorst, G (vol. 17, issue 5)
Click here to view article: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1432-2277.2004.tb00435.x